SCOPUS 정보 검색 플랫폼

Breast Journal

Volumn 17, Issue 4, 2011, Pages 434-435

Regulation of the angiogenesis inhibitor thrombospondin-1 by the breast cancer susceptibility gene-1 (BRCA1)

(5) Grillo, Jenny a Dellorusso, Christiana a Lynch, Ryan C a Folkman, Judah a Zaslavsky, Alexander b

a BOSTON CHILDREN S HOSPITAL (United States)

b UNIVERSITY OF PENNSYLVANIA (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOPOIETIN 1; BRCA1 PROTEIN; THROMBOSPONDIN 1; VASCULOTROPIN;

BREAST CANCER; CANCER CELL CULTURE; CANCER RISK; GENE FUNCTION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; LETTER; OVARY CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION; UPREGULATION;

ANGIOGENESIS INHIBITORS; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; HUMANS; THROMBOSPONDIN 1;

EID: 79960433293 PISSN: 1075122X EISSN: 15244741 Source Type: Journal
DOI: 10.1111/j.1524-4741.2011.01109.x Document Type: Letter

Times cited : (4)

References (7)

1
- 63049108452
- Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment
- Venkitaraman AR,. Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment. Annu Rev Pathol 2009; 4: 461-87.
- (2009) Annu Rev Pathol , vol.4 , pp. 461-487
- Venkitaraman, A.R.¹

2
- 0035057806
- BRCA1 and BRCA2 and the genetics of breast and ovarian cancer
- Welcsh PL, King MC,. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum Mol Genet 2001; 10: 705-13. (Pubitemid 32331579)
- (2001) Human Molecular Genetics , vol.10 , Issue.7 , pp. 705-713
- Welcsh, P.L.¹ King, M.-C.²

3
- 63549144514
- The complex relationship between BRCA1 and ERalpha in hereditary breast cancer
- Gorski JJ, Kennedy RD, Hosey AM, Harkin DP,. The complex relationship between BRCA1 and ERalpha in hereditary breast cancer. Clin Cancer Res 2009; 15: 1514-8.
- (2009) Clin Cancer Res , vol.15 , pp. 1514-1518
- Gorski, J.J.¹ Kennedy, R.D.² Hosey, A.M.³ Harkin, D.P.⁴

4
- 38449117440
- Molecular basis for estrogen receptor α deficiency in BRCA1-linked breast cancer
- DOI 10.1093/jnci/djm207
- Hosey AM, Gorski JJ, Murray MM, et al. Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer. J Natl Cancer Inst 2007; 99: 1683-94. (Pubitemid 351767217)
- (2007) Journal of the National Cancer Institute , vol.99 , Issue.22 , pp. 1683-1694
- Hosey, A.M.¹ Gorski, J.J.² Murray, M.M.³ Quinn, J.E.⁴ Chung, W.Y.⁵ Stewart, G.E.⁶ James, C.R.⁷ Farragher, S.M.⁸ Mulligan, J.M.⁹ Scott, A.N.¹⁰ Dervan, P.A.¹¹ Johnston, P.G.¹² Couch, F.J.¹³ Daly, P.A.¹⁴ Kay, E.¹⁵ McCann, A.¹⁶ Mullan, P.B.¹⁷ Harkin, D.P.¹⁸

5
- 0037206946
- Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells
- DOI 10.1038/sj.onc.1205971
- Kawai H, Li H, Chun P, Avraham S, Avraham HK,. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells. Oncogene 2002; 21: 7730-9. (Pubitemid 35398818)
- (2002) Oncogene , vol.21 , Issue.50 , pp. 7730-7739
- Kawai, H.¹ Li, H.² Chun, P.³ Avraham, S.⁴ Avraham, H.K.⁵

6
- 33745713176
- Removal of BRCA1/CtIP/ZBRK1 repressor complex on ANG1 promoter leads to accelerated mammary tumor growth contributed by prominent vasculature
- Furuta S, Wang JM, Wei S, et al. Removal of BRCA1/CtIP/ZBRK1 repressor complex on ANG1 promoter leads to accelerated mammary tumor growth contributed by prominent vasculature. Cancer Cell 2006; 10: 13-24.
- (2006) Cancer Cell , vol.10 , pp. 13-24
- Furuta, S.¹ Wang, J.M.² Wei, S.³

7
- 85013312416
- Tumor angiogenesis: Therapeutic implications
- Folkman J,. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182-6.
- (1971) N Engl J Med , vol.285 , pp. 1182-1186
- Folkman, J.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.